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Background, biology and significance of human
granzymes
Abstract
The human granzymes (Grz) are a highly conserved group of potent pep-
tidases that are found, together with a pore forming protein-perforin in
specialized granules of cytotoxic cells such as cytotoxic T lymphocytes
(CTLs) and natural killer (NK) cells. Granule exocytosis (perforin/Grz)
pathway is used by these cells to defend organism against virus-infected and
tumor cells by inducing them to undergo apoptosis. While the pro-apoptotic
functions of Grz have been well established, it has recently become apparent
that Grz also possess important extracelular activities which are now being
extensively investigated. Soluble Grz are found extracellularly in normal
plasma suggesting their constitutive secretion in healthy individuals via a
granule independent biosynthetic pathway. The potent activities of extra-
cellular Grz appear to be controlled by highly abundant plasma derived
serine peptidase inhibitors. However, unregulated activities of proteolytic
Grz have been shown to result in disease pathology especially, in the absence
of their corresponding inhibitors. To date, most of the studies have concen-
trated on the structure and function of granzyme A (GrA) and GrB while
very little work has been done on the remaining Grz which include GrM,
GrH and GrK in humans. In this report, we discuss the current knowledge
of Grz biochemistry, biology, functions, activity regulation and their role in
human pathology with special emphasis on the significance of human GrK
in this field.
EVOLUTION HISTORY AND GENE ORGANIZATION
OF GRANZYMES
The term granzymes or granule enzymes (Grz) was first employedalmost 20 years ago by Jenne et al. (1) to denote a group of highly
specific, evolutionary related serine peptidases, originally discovered in
the secretory granules of murine Cytotoxic T lymphocytes (CTLs).
Currently, Grz have been found only in humans and rodents. Charac-
terization of Grz have identified Granzyme (Gr) A, B, H, K, and M in
the granules of human cytotoxic cells and Gr A-G, K, L, M, and N in
the granules of murine cytotoxic cells (2, 3). The genes of these Grz are
separated on three chromosomal loci. GrA and GrK (tryptases) are
closely linked on chromosome 5 in humans and chromosome 13 in
mice. GrB (aspase) and GrH (chymase) are linked to cathepsin G on
human chromosome 14. The corresponding loci for Grz B, C, D, E, F,
and G and cathepsin G in the mouse are located on chromosone 14.
GrM (metase) is linked to neutrophil elastase (NE) and peptidase
3 on chromosome 19 in humans and chromosome 10 in mice (2).
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Interspecies comparison of cDNA sequences displays a
high degree of homology within the Grz of the same
group, as revealed by phylogenic analysis and shown in
Figure 1 (36). The expression of human Grz is mostly
restricted to CTLs and NK cells (5). However, it has
recently been reported that the genes of Grz are
heterogeneously expressed across the different subsets of
human cytotoxic cells (6). How the expression of genes
for these Grz is regulated under various physiological
conditions yet remains unknown. At the amino acid level
about 70% homology has been observed within any one
Grz subfamily, e.g., between mouse, rat and human GrB.
However, when Grz from different subfamilies are
compared, e.g., GrA and GrB, similarity of amino-acid
sequences falls to approximately 30–40%, even within
the same species (2).
GRANZYMES – A SERINE PEPTIDASES
FAMILY
Functionally, Grz belong to the family of serine
peptidases that are, after metallopeptidases, the second
largest class of protein-cleaving enzymes in the body.
The term »serine peptidase« indicates the importance of
a serine residue in the active center of the enzyme (7). A
common, highly conserved catalytic mechanism utilized
by serine peptidases is characterized by three key amino
acids: His, Asp and Ser in their active site which are often
referred to as a »catalytic triad«, and each of these amino
acids play an essential role in cleaving ability of serine
peptidases (7, 8). Although the catalytic triad provides a
unique mechanism by which to cleave substrate, it does
not determine substrate specificity. Serine peptidases
exhibit different substrate specificities because of their
ability to selectively cleave peptide bonds by restricted
amino acid residues. The cleavage site discrimination is
achieved primarily through selective binding of the ami-
no acid residue in the substrate that is N terminal to the
scissile bond, (P1 position) (nomenclature of Schechter
and Berger) (9). For efficient catalysis the P1 residue of
the substrate must tightly fit into the S1 substrate binding
pocket of the enzyme (9, 10). Interactions of other sub-
strate residues (P2, P3,…) with binding sites (S2, S3,…)
of the enzyme could amplify the substrate’s binding (8).
Therefore, some serine peptidases, as for instance Grz,
have an extended interaction site with the substrate
whereas the others have a specificity restricted to the P1
substrate residue (9, 10). Moreover, Grz were shown to
exhibit divergent extended substrate specificities as de-
termined by combinatorial libraries of their substrate
binding pocket residues (11). Valuable structural infor-
mation regarding substrate binding sites have also been
provided by molecular modeling of Grz (8) and by mu-
tation analysis of their substrate binding pocket residues
(12). These studies have been initiated to determine
optimum amino acid sequences that presumably repre-
sent natural protein sequence for Grz and thus, may help
to identify physiologically relevant substrates for Grz.
Initially, this correlation has been fulfilled for GrB. Ne-
vertheless, the identification of natural Grz substrates
has just begun and several important biological sub-





Serine peptidases share strong structural similarity
and are grouped into sub-families that share close se-
quence homology. The Grz contain the catalytic triad:
His57, Asp102 and Ser195 which is characteristics of chy-
motrypsin/trypsin sub-family (8) and exhibit one of four
enzymatic activities: GrA and K (tryptase) cleaves after
Arg or Lys, GrB (aspase) cleaves after Asp, GrM (metase)
cleaves after Met or Leu, and GrH (chymase) cleaves after
Phe, Tyr or Trp (8,12). Although, Grz are highly similar
to other chymotrypsin/trypsin-like enzymes (8), they
also have several defining characteristics. All mature Grz
have unique and conserved N-terminal Ile-Ile-Gly-Gly
sequence and highly conserved residues at the positions
9–16 (2). Their propeptide sequence is commonly
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Figure 1. Phylogenetic relationships among human and mouse Grz. Adopted from Grossman et al. 2003 Curr Opin Immunol (4).
Gly-Glu or Glu-Glu. They generally have three con-
served disulfide bridges, although GrA and GrM have
four. Only GrA has been characterized as a dimer con-
sisting of two disulphide linked monomers (2). Most
importantly, unlike other peptidases of the chymotryp-
sin/trypsin sub-family such as trypsin, chymotrypsin
and elastase that could cleave a very broad range of
substrates, Grz have very distinctive substrate specificity
which means that Grz also catalyze limited proteolysis
(2,12).
BIOGENESIS OF GRANZYMES
Grz are synthesized specifically by cytotoxic cells (5)
with the transcription of their messages primarily by
signaling initiated through binding of IL-2 or IL-15 and
IL-12 (13, 14). All Grz are initially translated as inactive
pre-pro-enzymes that require two separate amino-ter-
minal processing steps to become active (Figure 2). At
first, in the endoplasmic reticulum, the leader signal
peptide sequence is removed by a signal peptidase, leaving
a N-terminal pro-sequence consisting of two amino-acid
residues (pro-enzymes). Removal of this pro-dipeptide
occurs on the way to and/or at the time of packaging into
the secretory granules and requires activation by di-
peptidyl peptidase I (DPPI; also known as cathepsin C, a
cystein protease constitutively expressed in lysosomes)
(3, 5). The same activation process occurs for neutrophil
serine peptidase and for mast cells chymase (15). While
there is no doubt that the activity of DPPI is crucial for
activation of these serine peptidases (2, 3), the precise
compartment in which DPPI processes their pro-form is
still uncertain (16).
GRANULE DEPENDENT PATHWAY OF
GRANZYMES BIOSYNTHESIS
During biogenesis Grz are directed and sorted into
the secretory granules via the mannose-6-phosphate re-
ceptor (M6P-R) system (Figure 3). Therefore, in the
Golgi apparatus Grz undergo an important M6P oli-
gosaccharide modification of the N-linked glycans that
allows their recognition and sorting into the granules by
M6P-R (3, 17). Although, neutrophil and mast cell serine
peptidases share similar biogenesis, this M6P-R route
appears to be specific for sorting of Grz (15). Finally, the
packaging of positively charged Grz within the granules
is accomplished by non-covalent complex formation with
negatively charged granule proteoglycan (PG). This PG
has been called serglycin (SG) because it contains chron-
droitin 4-sulfate glycosaminoglycans linked to Ser-Gly
repeats in the central portion of the core protein (3). It
has been shown that approximately 30-50 Grz molecules
bind to each of ~250 kDa SG making the complex as big
as a viral particle (18). Furthermore, it has recently been
demonstrated that following activation of cytotoxic cells,
Grz are released from their granules in macromolecular
complexed form with SG. The same study showed that
Grz-SG complexes are proteolytically active (19). Never-
theless, the physiological role, if any, of such Grz-SG
complexes necessitate further investigation.
GRANULE INDEPENDENT PATHWAY OF
GRANZYMES BIOSYNTHESIS
An alternative, granule independent pathway of Grz
biosynthesis has been postulated (Figure 3). As demon-
strated by Isaaz et al. (17), during biosynthesis Grz may
not always enter secretory granules and therefore con-
sequently are directly secreted via a constitutive, non-
-granule biosynthetic pathway. This study also showed
that upon stimulation of CTLs, Grz could be secreted via
regulated pathway from the scretory granules and also by
the constitutive, non-granule pathway. In addition, Grz
were found de novo synthesized by these cells. The ma-
jority of newly synthesized Grz happened to be consti-
tutively extracellularly secreted while only minor part of
the newly synthesized Grz re-filled the granules (17).
However, the exact nature of such constitutive secretion
is not known, and ever since its recognition, this pathway
has received no or little attention.
ACTIVITY REGULATION – INHIBITORS
OF GRANZYMES
The potent activity of proteolytic Grz appears to be
regulated in several ways. At first, even if Grz are stored
inside granules as a fully active enzyme they still require
a neutral environment to mediate their function. There-
fore, the acidic pH inside granules prevents stored Grz
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Figure 2. The proteolytic activation of human Grz. A leader sequence consisting of 18-26 amino-acids residues (signal peptidases) of originally
synthesized inactive pre-pro-granzymes is cleaved by signal peptidases (1) resulting in a pro-granzymes. The removal of the pro-dipeptide sequence
(AA2-AA1) by DPPI (2) finally results in the fully active Grz (3) .
from degrading any proteins localized inside the gra-
nules. Once released from the secretory granules into
cytosol or extracellular space (neutral environment) Grz
are maximally active . It has been shown that cytotoxic
cells can synthesize their own intracellular serine pep-
tidase inhibitors called serpins. These serpins are absent
from the granules but present in the cytosol (pH around
7), and are thought to bind and neutralize mis-sorted or
mis-packaged Grz thereby preventing so called self de-
struction of effector cell . One such intracellular serpin is
PI-9 known to specifically inhibit GrB (5). Recently,
numerous novel intracellular serpins have been identi-
fied but their Grz specificities have to be characterized.
Constitutive levels of Grz have been detected in human
plasma (5, 22). The exact nature of Grz release into
extracellular environment is not fully understood. Theo-
retically, extracellular Grz may have originated from the
immunological synapse during killing of the targets, from
which they diffuse into the extracellular space as a free
Grz or in complexes associated with PG (20, 21). The
appearance of such extracellular Grz potentially, may be
a result of constitutive (non-specific) secretion by cyto-
toxic cells as observed after TCR (T cell receptor) trigger-
ing, or prolonged exposure to interleukin (IL-2) (5, 22).
Furthermore, several studies have demonstrated that the
matrix associated proteins vitronectin and fibronectin
through interaction with CTL provide a co-stimulatory
signal that could induce release of stored Grz (5). The
presence of bacteria has been shown to induce Grz release
from lymphocytes via yet unknown mechanism (23).
However, under normal circumstances, there are physio-
logical inhibitors (naturally occurring extracellular ser-
pins) present in the plasma that bind to and form com-
plexes with these extracellular Grz, and thereby inhibit
their potent proteolytic activity (Figure 3). Serpins act as
pseudosubstrates and exert their inhibitory effects by
presenting their reactive site as an ideal substrate for the
peptidase that leads to a reaction that traps the enzyme
and distorts the catalytic site (15). All members of the
serpin family share a high degree of structural homology,
but are highly specific when targeting serine peptidases.
Some of these physiological inhibitors include anti-
thrombin-III (AT-III) and á2-macroglobulin (á2-MG)
for GrA , and Inter-alpha-inhibitor proteins (IaIp) for
GrK . Although alpha-1-antitrypsin was believed to be a
physiological inhibitor of GrB, recent studies suggest
that is not the case . It also appears that these inhibitors
are not able to inhibit Grz activity when the Grz are
complexed with PG (5, 27). It has been observed that
activity of Grz in the absence of corresponding inhibitors
may result in disease pathology (30, 31) as will be dis-
cussed later.
BIOLOGICAL SIGNIFICANCE OF HUMAN
GRANZYMES
Intracellular functions – granzymes and
apoptosis
Ever since discovery of target cell killing by cytotoxic
cells, much effort has been devoted to understanding the
lytic mechanisms involved in this process. A variety of
independent studies have supported the original concept
that proteolytic Grz are critically involved in the cyto-
toxic event during granule exocytosis as shown in Figure
4 (32). In brief, following recognition and conjugation
with a target cell, the cyototxic granules migrate from
their dispersed locations in the cytosol to the immuno-
logical synapse, where their membranes fuse with the
cytotoxic cell plasma membrane, that enable them to
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Figure 3. Biogenesis of human Grz. Constitutive versus regulated secretion. Pro-apoptotic and extracellular Grz functions and its extracellular
activities regulation by specific physiological inhibitors.
release their granular contents into the intracellular
space (18). Grz are than internalized by the target cell in
a manner that remains controversial, but which results in
their accumulation in endosome-like vesicles (5). Cyto-
plasmic entry of Grz and induction of cell death, a pro-
cess which is also known as membrane attack or 'lethal
hit', is than critically dependent on the action of pore
forming protein/perforin (18). The 'lethal hit' happens
very rapidly after contact with target cells. At this point
cytotoxic cell can dissociate while the target cell is
committed to die by apoptosis. Following dissociation,
cytotoxic cells can seek another target up to twenty times,
yet remain undamaged (17).
The mechanisms of cell death induction have been
extensively studied for only GrA and GrB. Several of
apoptotic mechanisms induced by these Grz have been
elucidated, and some of their intracellular substrates
have been identified (3, 22). The first and most studied
effector molecule, GrB, is now recognized as the most
powerful apoptosis inducing molecule. GrB initiates cell
death rapidly by inducing an early DNA fragmentation,
mainly through the caspase activation pathway. Many
studies confirmed that GrB activates a number of pro-
caspases (including -2, -3, -7-10) directly, but in most
cases it involves indirect activation of caspases through
activation of the mitochondrial pathway by the cleaving
of a mitochondrial, pro-apoptotic Bcl-2 family member
called Bid (2). Recently, various caspase independent
pathways have also been suggested for GrB and are yet to
be more fully defined (3, 34). Next to GrB, GrA ef-
fectively initiates cell death, however, via an alternative
pathway that is clearly caspase independent (5). The
exact mechanisms by which GrA induces cell death are
only partly understood and are currently being widely
studied. The apoptotic effects of GrA were demonstrated
by delivery of purified GrA into the target cell which
resulted in apoptotic features such as DNA fragmenta-
tion, loss of mitochondrial transmembrane potential and
generation of oxygen species (18). GrA has also been
shown to cleave several important nuclear proteins in-
cluding lamins and histones. Recently, endoplasmic
reticulum associated complex, known as the SET com-
plex has been recognized as a special target for GrA
possibly inducing a novel form of DNA damage (18).
The physiological relevance of GrA and GrB in inducing
apoptosis has been confirmed in a study with mice defi-
cient in GrA(-/-) and/or GrB(-/-). This study demon-
strated that CTL derived from GrA(-/-) or GrB(-/-) mice
similarly induced early proapoptotic features but with
distinct kinetics. Consistent with in vitro findings, CTL
from GrA(-/-) but not from GrB(-/-) mice activated
caspase 3 and 9 (34). Undoubtably, Grz are now well
recognized as the principal effector molecules that play
indispensable roles in initiating the process of apoptosis
('programmed' death of the cell) in virus-infected and
tumor and/or other potentially harmful cells (32). How-
ever, it is still not clear if the Grz-induced apoptotic
features are perforin dependent (18). Recent evidences
derived from studies in perforin deficient mice strongly
indicated that the proteolytic activities by which Grz
initiate the process of apoptosis in cytosol and/or nucleus
of the target cells are critically perforin dependent (34). A
clear mechanistic explanation supporting such perforin
and Grz synergy remains undefined.
Extracellular functions of granzymes
Based on the findings that Grz also appear extra-
cellularly (5, 35), a number of important extracellular
functions have been postulated for these peptidases. Grz
were shown to cleave a number of extracellular matrix
components (EMC) (5, 36), to induce cytokine secretion
and/or to directly activate cytokines (20, 21, 37). Further-
more, the role of Grz in proteolytic activation of the
peptidase-activated receptor (PAR) family has been
postulated (5). Together, these observations strongly sug-
gest that extracellular Grz possess important pro-inflam-
matory properties which may result in pathological con-
sequences. Thus, these extracellular activities of Grz are
now being widely investigated.
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Figure 4. The granule exocytosis pathway of cytotoxic cell killing. This pathway is not a single, but rather a sequence of events that includes several
major steps as: conjugate formation, membrane attack, cytotoxic cell dissociation and target-cell destruction. Modified from Goldsby et al. .
Cleavage of extracellular matrix
proteins
The involvement of Grz in disrupting extracellular
matrix integrity was demonstrated by the ability of GrA
to cleave components of the extracellular matrix such as
PG, collagen type IV, laminin, and fibronectin (2, 5, 36).
In addition, GrA has been shown to activate the pro-
enzyme of urokinase-type plasminogen activator, which
activates plasmin, an enzyme that is also very effective at
degrading extracellular matrix (5, 36). Recently, it has
been illustrated that, like GrA, GrB can also cleave EMC.
GrB degrades PG in matrix synthesized by chondro-
cytes, and specifically, the abundant structural PG of
cartilage, aggrecan (5). The number of extracellular sub-
strates identified for human GrB continues to increase.
Such disruption of EMC causes protein leakage, and
thereby facilitates entry and migration of innate cells
through tissues or extravasation (36). More importantly,
it has been recently reported that components generated
by the cleavage of extracellular matrix could either di-
rectly or indirectly trigger the inflammatory response
leading to systemic inflammation/sepsis and its related
conditions (25).
Cytokine secretion and/or activation
The inflammatory properties of Grz have also been
demonstrated by their ability to exert other biological
responses such as, the induction of cytokine production
and secretion (2). Next to thrombin, another peptidase
with trypsin-like activity, purified human GrA has been
shown to induce human lung fibroblasts and epithelial
cell lines to produce IL-6 (21). Furthermore, GrA was
also shown to induce the production of IL-6, IL-8, and
tumor necrosis factor (TNF)-a by human peripheral
blood mononuclear cells and purified monocytes and to
enhance the phagocytic activity of monocytes. Impor-
tantly, induction by thrombin resulted only in increased
IL-8 production and enhanced phagocytosis, but did not
induce IL-6 or TNF-a production (20). Grz have also
been implicated in proteolytic activation of certain cyto-
kines. GrA has been shown to directly activate the pro-
inflammatory cytokine IL-1b by cleaving off its pro-
peptide (37). In addition, GrA was suggested to activate
PAR-2 receptor (5). However, the precise role of Grz in
such activation is unknown.
ORPHAN GRANZYMES
The current understanding of the molecular basis of
apoptotic cell death, principally obtained with GrA and
GrB, has revealed the complexity of intracellular events
involved. The remaining Grz that are reffered to as
»orphan Grz« have been largely neglected and for a long
time considered functionally redundant. The role of
these Grz in apoptosis became evident from the studies
in which cytotoxic cells derived from mice with complete
absence of both, GrA and GrB (double knockout) re-
tained ability to kill certain susceptible targets . Although
apoptotic pathways and target cellular substrates of or-
phan Grz are largely unknown, it may well be that
different Grz induce independent cell death pathways in
host response to circumvent targets. Likewise, these re-
maining Grz may also exhibit an array of potentially




Grz and enzymes that regulate their activity have
been associated with certain human pathological con-
ditions. As cells involved in the major defense of higher
organisms, cytotoxic lymphocytes have been acknow-
ledged to detect and eliminate potentially harmful cells
by inducing them to undergo apoptosis (22). However, it
has been observed that upon cytotoxic cells activation a
significant amount of Grz appeared in human plasma (5,
23). As previously mentioned, peptidase inhibitors are
usually present in the body at very high concentrations
and their proposed function is to inhibit the potential
bystander effects of these peptidases thus, preventing
them from damaging normal structures. Under certain
conditions, a lack of specific peptidase inhibitors can
result in disease pathology when serine peptidases are
present (38). For example, hypersensitivity pneumonitis
(HP) results from uninhibited GrA and GrB in the lung
as a result of accumulation of activated alveolar CTLs
and NK cells in response to allergens. The fact that
neither one of the three main serine peptidase inhibitors
of the lung, namely a1-antitrypsin, secretory leukocyte
peptidase inhibitor, and elafin could inhibit GrA or GrB
activity clearly indicates that HP occurs as a result of
uncontrolled proteolysis that leads to tissue damage and
inflammation (29). This finding is further supported by
the observation that individuals that have an inherited
deficiency of a1-antitrypsin activity show an accelerated
and enhanced development of emphysema. The basis for
the development of emphysema is that the inactive a1-
antitrypsin present in the lung is unable to inhibit the
activity of NE that consequently results in damaging the
lung tissue (30, 31). Furthermore, elevated plasma levels
of GrA and GrB have been associated with systemic
inflammation/sepsis. The injection of LPS (lipopoly-
saccharide), believed to be a major trigger of sepsis, into
human volunteers was found to induce a 5 fold increase
in soluble GrA that peaked at 2 hrs after injection and
also resulted in an increase of soluble GrB that peaked at
6 hrs (23). Examination of patients with melioidosis
indicated that GrA levels were significantly elevated in
patients with bacterimic melioidosis compared to con-
trols. In these patients, levels of GrA correlated with
mortality. GrB levels were significantly higher in patients
with bacterimic melioidosis, but there was no difference
between the group of survivors and nonsurvivors (23).
These investigators went on to show that addition of heat
killed bacteria to whole blood resulted in a significant
increase in the levels of GrA and GrB. Direct mea-
surement of Grz also indicated that levels of GrA and
GrB were elevated in a subset of septic patients (39).
High levels of GrA and GrzB have been observed in
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plasma of infectious mononucleosis patients (40). More-
over, soluble GrA and GrB levels were elevated in an
array of pathophysiological situations such as infection
with intracellular pathogens, graft versus host disease,
susceptibility to transplantable and spontaneous malig-
nancies, the lymphoid homeostasis, rheumatoid arthritis
and autoimmune disease (5, 12). Molecular mechanism




To date, there had been little investigation into the
role of human GrH, GrM and GrK although, their in-
volvement in immune responses is being recognized (4).
Most recently, our laboratory provided new evidence
concerning functional importance of GrK. Similar to
GrA and GrB, we observed that low constitutive levels of
GrK existed extracellularly in normal plasma. Impor-
tantly, our data also revealed that plasma GrK levels
correlated with the stage of sepsis and that free, uninhi-
bited GrK molecule appeared in sepsis patients along
with the loss of its respective physiological inhibitor, IaIp
in plasma (35). Thus, our findings strongly indicate that
the presence of unhibited GrK, as a potent peptidase may
contribute to the development of sepsis and related in-
flammatory conditions. In addition, functional signi-
ficance of GrK has been highlighted by several other
studies. GrK mediates tryptic activity in complete ab-
sence of second Grz-tryptase, GrA as demonstrated in
mice in which GrA was genetically deleted. At the same
time, in these mice GrK expression was unimpaired.
This same study illustrated minimal cytotoxic defect in
these GrA deficient mice that could be due to the per-
sistent expression of additional tryptase, GrK (41). Fur-
thermore, the potential of GrK to induce apoptosis has
been reported (41, 42). Once delivered into the target cell
along with sublytic dose of perforin, GrK has been shown
to induce cell death by late release of DNA in a fashion
similar to GrA. However, it does not cause typical apop-
totic nuclear morphology observed with GrA and GrB,
suggesting that GrK may use a unique pathway in killing
susceptible targets (18). In the recent study, Bade et. al.
demonstrated that GrK expression and regulation pattern
differs from that of other Grz across different subsets of
cytotoxic cells (22). This study further suggests that GrK
might exhibit potentially significant functions under cer-
tain physiological conditions. In addition, significantly
elevated GrK levels were observed in patients with several
viral infections suggesting that GrK actively participates
in innate responses against certain viruses. However, the
target cellular substrate for GrK and the molecular mecha-
nism of its function remain unknown.
BACKGROUND AND CURRENT BIOLOGY
OF HUMAN GRANZYME K
Granzyme K, a 26 kDa protein was originally dis-
covered as granzyme 3 in granules of human lymphokine
activated killer cells (28). It is most similar to GrA. Both
proteins are tryptases and are encoded by closely linked
genes located on the same human chromosome, (5q11-12)
(43). However, GrK differs from GrA on the basis of its
amino acid sequence and monomeric structure (44).
Human recombinant GrK (recGrK) has been expressed
in Escherichia coli as a pro-Grz and was obtained cata-
lytically active following cleavage by DPPI (28). Hirata
et al. used the same recombinat technology and obtained
catalytically active recGrK without refolding or di-pep-
tide deletion (45). Recently, we obtained catalytically
active native human GrK from NK 92MI cells secretory
granules by using a method for rapid isolation of granular
proteases (35). In addition, GrK appeared extracellularly
secreted by these NK cells thus suggesting the existence
of a constitutive, non-granule biosynthetic pathway (un-
published data). While it is reasonable to assume that
GrK as well is sorted to the secretory granules via M6P
recognition signal, the nature of the mechanism res-
ponsible for its constitutive secretion yet remains un-
known. During biogenesis, GrK might escape a M6P
oligosaccharide modification of the N-linked glycans,
then consequently fails to acquire the M6P receptor gra-
nule-targeting signal and thus may be directly secreted.
Previous data support a similar scheme for constitutive
secretion of GrB but not GrA by TCR triggered CTLs (17).
An alternative biosynthetic pathway, commonly suggest-
ed for hematopoietic serine peptidases, is the absence of
DPPI during biosynthesis and processing that then re-
sults in direct secretion of the pro-enzyme forms (15, 46).
In any case, such constitutive secretion supports the idea
that GrK fulfils additional extracellular functions apart
from its pro-apoptotic role in the well regulated lytic
events occurring during NK and/or CTL lysis of target
cells (41). In analogy to GrA, as the closest structural and
functional relative of GrK (43), it could be anticipated
that GrK might cleave extracellular matrix proteins or
might proteolytically process as of yet, unidentified me-
diators of inflammation (5, 20, 21) . Although, both are
tryptases, GrK might differ from GrA on the basis on its
structural characteristics and its distinctive substrate
cleaving specificity (2, 11). Furthermore, the proteolytic
activities of these, though similar Grz-tryptases is dif-
ferentially regulated. IaIp of human plasma had been
shown to effectively inhibit extracellular GrK activity
(28), while the major physiological inhibitor of GrA,
AT-III was ineffective in inhibiting GrK (28).
In summary the current findings demonstrate that
different Grz exhibit distinctive substrate specificities,
that are heterogeneously expressed across different cyto-
toxic cell subsets and may induce multiple independent
cell death pathways indicating, that each one of the Grz
might play specific functions under certain physiologic
situation. It become evident that Grz also possess extra-
cellular activites and that the levels of extracellular Grz
are elevated in a number of diseases. However, what are
the exact physiological functions; and the pathological
consequences of extracellular Grz in diseases and, how
their activities are regulated in specific situations re-
mains to be defined. In addition, an insight into GrK
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biology and function is now being clearly revealed. Thus,
detail characterization of human GrK is required to
define the exact physiological substrate and the mole-
cular mechanism(s) of its actions in human physiology
and pathology.
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